Sun Pharma plans expansion programme at Palashbari

Sun Pharma has commissioned a new production line at its manufacturing facility in Palashbari in the outskirts of city Guwahati in Assam. The company has invested over ₹ 1200 million in the new production line, which will produce liquid vials, injectable, eye drops and tablets.

It may be noted that, the company has invested over ₹ 7000 million in the facility and is likely to invest a further ₹ 2000 million to make it the largest production plant to produce sterile.

Company Profile : Sun Pharmaceutical Industries Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.